welcome to the sikora lab
The Sikora Lab was launched in August 2016. As a new research group focusing on invasive lobular carcinoma of the breast, we strive to create an environment where our staff and early-career researchers (ECRs; students, postdocs, and fellows) can advance both our collective research efforts and their own unique training and career development goals.
AT THE BENCH
Understand steroid hormone signaling in cancer, with a focus on response to endocrine therapy and anti-estrogen resistance in breast cancer.
Understand steroid hormone signaling mechanisms in invasive lobular carcinoma of the breast.
TOWARD THE CLINIC
Improve the outcomes of patients with hormone-dependent breast cancer and other cancers primarily affecting women.
FOR OUR RESEARCH COMMUNITY
Train productive, collaborative, and responsible members of the scientific community.
Grants and Awards
Golfers Against Cancer (GAC) - Denver: The Sikora Lab received a pilot grant from GAC to advance our WNT4 research toward developing new treatments for ovarian cancer, and understanding patient risk of developing ovarian cancer.
Lobular Breast Cancer Alliance (LBCA): Dr. Sikora joined the #lobmob as a member of the Scientific Advisory Board. Working closely with ILC patient advocates keeps our research focused on the needs of patients!
FOLLOW US ON TWITTER
The PI: @mjsikora
The Lab: @SikoraLab